Back to results
US 2020/0270584 A1Published application
Method for rapid generation of an attenuated rna virus
AssigneesUniversite D'Aix-Marseille, Inserm
InventorsAntoine Nougairéde, Lauriane De Fabritus, Fabien Aubry, Xavier De Lamballerie, Ernest Andrew Gould
Life of this patent
Estimating the term…
Abstract
The present invention harnesses the power of mutagenesis to produce an attenuated RNA virus in a very short period, i.e. as soon as the complete sequence of the target virus is known and an infectious genome can be produced.
Claims9
1-13. (canceled)
A vaccine comprising cDNA fragments, wherein said cDNA fragments are overlapping cDNA fragments obtained by:
- introducing a promoter of DNA-dependent RNA polymerase in position 5′ and optionally a terminator and a RNA polyadenylation sequence in position 3′ of a re-encoded viral genome;
- amplifying said re-encoded viral genome in at least 2, preferably at least 3, 4, 5 or 6 overlapping cDNA fragments;
- wherein said re-encoded viral genome is obtained by re-encoding the viral genome of an infectious RNA virus by randomly substituting a part of the nucleotide codons of the entire viral genome of said infectious RNA virus by another nucleotide codon encoding for the same amino acid,
- with the proviso that:
- the number and position of rare nucleotide codons present in said viral genome are not modified, said rare nucleotide codons being CGU, CGC, CGA, CGG, UCG, CCG, GCG and ACG;
- and
- the regions of said viral genome which are involved with RNA secondary structure are not modified.
4 more elements
Dependencies are inferred from the claim text.